Breast Cancer is the Most Feared Cancer Among Women in Germany, Although Less than Half are Aware of the Benefits of Genomic Testing
KANTAR survey: Only 40% of breast cancer patients know the Read More
KANTAR survey: Only 40% of breast cancer patients know the Read More
Flash Mob for Breast Cancer Empowerment, in partnership with the Read More
PUBLICATION: J Breast Cancer. 2017 Sep;20(3):246-253. English. Published online Sep Read More
First time 10-year prospective outcome data confirms clinical utility of Read More
PUBLICATION: Journal of Clinical Oncology 35, no. 24 (August 20, Read More
ASCO® recommends MammaPrint® for clinical high risk, hormone receptor-positive, HER2-negative Read More
IRVINE, CA and AMSTERDAM – 6 July 2017 - Agendia, Read More
PUBLICATION: European Journal of Cancer. July 2017, Volume 79, Pages Read More
PUBLICATION: Breast Cancer Res Treat. 2017 Oct;117(3):483-95. doi: 10.1007/s10549-008-0191-2. Epub Read More
Retrospective analysis of patient samples from the prospective, randomized Stockholm Read More